Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $9.6 million.

  • Bioventus' Net Cash Flow fell 910.12% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $915000.0, marking a year-over-year decrease of 9441.26%. This contributed to the annual value of $7.2 million for FY2024, which is 6050.18% down from last year.
  • As of Q3 2025, Bioventus' Net Cash Flow stood at $9.6 million, which was down 910.12% from $9.9 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Net Cash Flow registered a high of $42.8 million during Q2 2021, and its lowest value of -$41.4 million during Q3 2022.
  • For the 5-year period, Bioventus' Net Cash Flow averaged around -$1.6 million, with its median value being -$2.1 million (2023).
  • Per our database at Business Quant, Bioventus' Net Cash Flow plummeted by 58378.09% in 2022 and then skyrocketed by 60018.85% in 2024.
  • Over the past 5 years, Bioventus' Net Cash Flow (Quarter) stood at -$31.9 million in 2021, then skyrocketed by 88.71% to -$3.6 million in 2022, then soared by 371.59% to $9.8 million in 2023, then plummeted by 94.15% to $571000.0 in 2024, then surged by 1589.67% to $9.6 million in 2025.
  • Its Net Cash Flow was $9.6 million in Q3 2025, compared to $9.9 million in Q2 2025 and -$19.2 million in Q1 2025.